Accuray Seeks Broader Use Of CyberKnife As Credit Crunch Hurts Growth
This article was originally published in The Gray Sheet
Executive Summary
Robotic radiosurgical system maker Accuray is continuing to collect data to support broader use of its CyberKnife system for cancer treatments even as it lowers 2008 revenue expectations citing a credit crunch for some U.S. purchasers
You may also be interested in...
Digital Health In Brief
Latest on mobile health, telemedicine and other digital developments.
Accuray Puts Emphasis On Hospitals As More Stable Revenue Source
Accuray's strategy of ramping up sales efforts to hospital customers for its CyberKnife robotic radiosurgery system and taking the focus off freestanding radiology sites has aided the company during a challenging year, the firm said last week
Accuray Puts Emphasis On Hospitals As More Stable Revenue Source
Accuray's strategy of ramping up sales efforts to hospital customers for its CyberKnife robotic radiosurgery system and taking the focus off freestanding radiology sites has aided the company during a challenging year, the firm said last week